Form 8-K Bausch Health Companies For: Nov 03

Go back to Form 8-K Bausch Health Companies For: Nov 03

Bausch Health Companies (BHC) PT Lowered to $14 at Stifel

November 3, 2022 1:23 PM EDT

Stifel analyst Annabel Samimy lowered the price target on Bausch Health Companies (NYSE: BHC) to $14.00 (from $15.00) while maintaining a Buy rating following results.

The analyst commented, "Remaining committed to the BLCO separation, BHC reported a lower 3Q22, with revenues of $2,046mn/Cons.... More

Bausch Health Companies (BHC) PT Lowered to $35 at Cowen

November 3, 2022 11:45 AM EDT

Cowen analyst Ken Cacciatore lowered the price target on Bausch Health Companies (NYSE: BHC) to $35.00 (from $40.00) while maintaining a Outperform rating following results.

The analyst commented, "Q3 revs reached $2.05B, in line, driven by recovery in all major segments including Salix, Solta, and... More